Lancôme Unveils Revolutionary Absolue Longevity MD Skincare Collection
Lancôme has made a significant stride in the skincare industry with the launch of its most ambitious innovation in two decades, the Absolue Longevity MD collection. This groundbreaking collection, unveiled on May 1, 2026, at an immersive event in New York City, marks a shift from traditional anti-aging to science-backed skin longevity. The event was graced by the presence of newly appointed ambassadors Demi Moore and Zoe Saldaña.
The Absolue Longevity MD collection introduces a revolutionary approach to skincare. It focuses on reversing visible biological aging at every life stage. The core of this collection is Mitopure®, a proprietary ingredient developed in collaboration with Swiss biotech company Timeline®. Mitopure® targets cellular health and mitochondrial function, promoting overall skin health.
What sets this launch apart is Lancôme’s formation of the first-ever Longevity MD Advisors Board. This board comprises board-certified physicians including Dr. Gabrielle Lyon, Dr. David Luu, Dr. Amy Killen, and Dr. Tiffany Moon. In addition, the brand introduced Cell BioPrint™, a diagnostic device that analyzes five skin-surface biomarkers. This device interprets visible biological age and generates personalized skincare protocols, making skincare more tailored and effective.
The Absolue Longevity MD range includes three phase-specific formulations:
- Anticipate (for under 35)
- Intercept (for midlife)
- Reset (for mature skin)
These formulations are priced between $155-$175. Clinical studies demonstrate impressive results. The formulas boost longevity cell metabolism by 80%, increase type I collagen production by 170%, and type III by 415%. After one month of use, signs of aging can reverse by five years, making this collection a game-changer in the skincare industry.
Source: www.beautypackaging.com